PIQ-PHARMA is one of the few Russian companies producing not only finished dosage forms, but pharmaceutical substances as well, which allows for assuring high quality of products on all stages of creation of a drug.
The production base of the company is comprised of the plant for production of finished pharmaceutical products and an enterprise for chemical synthesis of pharmaceutical substances. Its own production base allows PIQ-PHARMA to implement new dosage forms at an increased rate as well as to produce the present product range.
The company includes departments for development, registration, promotion and sale of modern effective medical products.
Since its establishment in 1994, PIQ-PHARMA has been working together with research centers, supporting promising scientific research projects in Russian biochemistry and pharmacology. Basing on the research results, the company creates and brings to the final consumer highly effective means of treatment and prevention of diseases.
The company has its own production base, conforming to the European quality standards for pharmaceutical production.
Currently the company has 13 drugs in its portfolio. These are metabolic, cardiovascular and nootropic drugs that have proven in practice its effectiveness in treatment and prevention of a wide range of diseases. Over 10 preparations of various therapeutic categories are on various stages of development.
Drugs produced by the company are widely known and are recommended for use by leading medical specialists in pediatry, psychoneurology, endocrinology, cardiology, neurology.
PIQ-PHARMA LEK manufacturing site was designed and constructed in compliance with GMP rules. Complex engineering solutions provide all required parameters: clean room grade, air exchange rate, climate conditions, and excessive air pressure for technological and utility rooms. The site is equipped with modern machinery from Western suppliers: IMA (Italy), KILIAN (Germany), ROMACO (Germany). The site staff is professional and well-trained. The quality system has been elaborated and implemented.
The new warehouse designed for 1300 pallets is the inseparable part of PIQ-PHARMA LEK production site. The warehouse is equipped with climate control system in order to store raw materials and final products. The new modern tracking system is implemented.
The designed production capacity is 500 mln tablets, and 350 mln capsules annually. At the moment the capacities are not totally loaded, that is why, PIQ-PHARMA LEK company can place the contract manufacturing of products, up to 350 mln tablets annually. In the nearest future (1-1,5 year) the launch of liquid dosage forms division (syrups, solutions, suspensions) is planned. Its designed capacity is up to 10 mln. bottles annually.
Group of companies PIQ-PHARMA suggests partnership in contract manufacturing of products for pharmaceutical companies having no their own production sites, or for companies interested in localization of foreign products in Russia. We can help with manufacturing of both solid and liquid dosage forms. We are ready to provide elaboration or adaptation of production technology in our own technological lab, and administer the registration of finished products in Russia.
Quality Assurance System at PIQ-PHARMA LEK production site imply control at every stage of production, including the control of raw materials, finished products, documentation management, and personnel training.
Quality control lab is equipped with all required instrumentation which allow implementation almost of all methods applied in pharmaceutical industry:
- Atomic adsorption
- IR spectroscopy
- All other basic analytic methods (titration, etc)